Constitutive Activation of Neuregulin/ERBB3 Signaling Pathway in Clear Cell Sarcoma of Soft Tissue
Open Access
- 1 July 2006
- journal article
- Published by Elsevier BV in Neoplasia
- Vol. 8 (7), 613-622
- https://doi.org/10.1593/neo.06238
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- The epidermal growth factor receptor gene family as a target for therapeutic intervention in numerous cancers: what’s genetics got to do with it?Emerging Therapeutic Targets, 2005
- Prognostic and therapeutic relevance of HER2 expression in osteosarcoma and Ewing’s sarcomaEuropean Journal Of Cancer, 2005
- ERBB receptors and cancer: the complexity of targeted inhibitorsNature Reviews Cancer, 2005
- Neuregulin‐1 enhances survival of human astrocytic glioma cellsGlia, 2005
- Expression Profiling of t(12;22) Positive Clear Cell Sarcoma of Soft Tissue Cell Lines Reveals Characteristic Up-Regulation of Potential New Marker Genes Including ERBB3 Cancer Research, 2004
- The ErbB receptors and their role in cancer progressionExperimental Cell Research, 2003
- The EGFR family and its ligands in human cancerEuropean Journal Of Cancer, 2001
- Deletions below 10 megabasepairs are detected in comparative genomic hybridization by standard reference intervalsGenes, Chromosomes and Cancer, 1999
- Comparative Genomic Hybridization for Molecular Cytogenetic Analysis of Solid TumorsScience, 1992
- Malignant melanoma of soft partsThe American Journal of Surgical Pathology, 1983